Yüklüyor......
c-Met targeted therapy of cholangiocarcinoma
Cholangiocarcinoma continues to be a challenging disease to treat. Systemic therapy is used in unresectable disease, disease progression after surgery, and in the palliative setting. Unfortunately, results of multiple phase II trials have rarely yielded positive results. As data on the molecular car...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
The WJG Press and Baishideng
2008
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2712164/ https://ncbi.nlm.nih.gov/pubmed/18494048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.14.2990 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|